Process for the manufacture of organic compounds

Details for Australian Patent Application No. 2006225205 (hide)

Owner Novartis AG

Inventors Chen, Guang-Pei; Girgis, Michael J.; Loeser, Eric M.; Zaugg, Werner; Kapa, Prasad Koteswara; Beutler, Ulrich

Agent Davies Collison Cave

Pub. Number AU-B-2006225205

Parent 2003239294

Filing date 3 October 2006

Wipo publication date 26 October 2006

Acceptance publication date 6 August 2009

International Classifications

C07D 215/14 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07B 53/00 (2006.01) Asymmetric syntheses

C07B 61/00 (2006.01) Other general methods

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

19 October 2006 Complete Application Filed

26 October 2006 Application Open to Public Inspection

  Published as AU-B-2006225205

6 August 2009 Application Accepted

  Published as AU-B-2006225205

3 December 2009 Standard Patent Sealed

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006225206-Process for the manufacture of organic compounds

2006225204-Cold-adapted equine influenza virus